Swissmedic Approves Extension of Therapeutic Indication for Nubeqa
PUBLISHED: January 29, 2026 Swissmedic has announced the approval of an extension of therapeutic indication for Nubeqa, a significant development […]
PUBLISHED: January 29, 2026 Swissmedic has announced the approval of an extension of therapeutic indication for Nubeqa, a significant development […]
Published on 2026-01-28, a critical medical device alert has been issued for Arixtra solution for injection pre-filled syringes due to
Class Action Attorney Juan Monteverde with Monteverde & Associates PC is investigating the mergers of Burke & Herbert Financial Services
The ultrasound devices market is projected to grow significantly, reaching approximately $15.23 billion by 2033, up from $9.84 billion in
On January 28, 2026, Swissmedic released a statement regarding Ocrevus (ocrelizumab), a medication used to treat multiple sclerosis. The update
Meta description: Blumont Pharma Limited issues recall for Ocumont Eye Ointment due to missing Braille labeling on outer cartons. Published
Published on 2026-01-27T22:01:44.000Z, the Medicines and Healthcare products Regulatory Agency (MHRA) has released its latest safety roundup, highlighting crucial updates
As of 27 January 2026, several field safety notices have been issued, affecting various medical devices. These notices are crucial
Civitas oil and gas company is facing a lawsuit from its shareholders as it navigates a $12.8B merger. The lawsuit
On January 27, 2026, Swissmedic announced the extension of the therapeutic indication for Hepcludex, a medication used to treat a